- Home
- A-Z Publications
- Recent Patents on Biotechnology
- Previous Issues
- Volume 15, Issue 4, 2021
Recent Patents on Biotechnology - Volume 15, Issue 4, 2021

Volume 15, Issue 4, 2021
-
-
Technological Prospecting: Mapping Patents on L-asparaginases from Extremophilic Microorganisms
Authors: Igor G. de Oliveira Lima, James R. S. Bispo, Maurício Bernardo da Silva, Alexya de Oliveira Feitosa, Ana Caroline Melo dos Santos, Magna Suzana Alexandre Moreira, Michel Rodrigo Zambrano Passarini, Paulo Eduardo Aguiar Saraiva Câmara, Luiz Henrique Rosa, Valéria Maia Oliveira, Aline Cavalcanti de Queiroz and Alysson Wagner Fernandes DuarteBackground: L-asparaginase (L-ASNase, L-asparagine amidohydrolase, E.C.3.5.1.1) is an enzyme with wide therapeutic applicability. Currently, the commercialized L-ASNase comes from mesophilic organisms, presenting low specificity to the substrate and limitations regarding thermostability and active pH range. Such factors prevent the maximum performance of the enzyme in different applications. Therefore, extremophilic Read More
-
-
-
Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach
Authors: Mekha Rajeev, Chameli Ratan, Karthik Krishnan and Meenu VijayanBackground: Hutchinson-Gilford progeria syndrome (HGPS), also known as progeria of childhood or progeria is a rare, rapid, autosomal dominant genetic disorder characterized by premature aging which occurs shortly after birth. HGPS occurs as a result of de novo point mutation in the gene recognized as LMNA gene that encodes two proteins, Lamin A protein and Lamin C protein which are the structural components of the n Read More
-
-
-
Computational Elucidation of Phylogenetic, Functional and Structural Features of Methioninase from Pseudomonas, Escherichia, Clostridium and Citrobacter Strains
Authors: Cambyz Irajie, Milad Mohkam, Bahareh Vakili and Navid NezafatBackground: L-Methioninase (EC 4.4.1.11; MGL) is a pyridoxal phosphate (PLP)-dependent enzyme that is produced by a variety of bacteria, fungi, and plants. L-methioninase, especially from Pseudomonas and Citrobacter sp., is considered as the efficient therapeutic enzyme, particularly in cancers such as glioblastomas, medulloblastoma, and neuroblastoma that are more sensitive to methionine starvation. Objective: The lo Read More
-
-
-
Finding Appropriate Signal Peptides for Secretory Production of Recombinant Glucarpidase: An In Silico Method
Background: Methotrexate (MTX) is a general chemotherapeutic agent utilized to treat a variety of malignancies, woefully, its high doses can cause nephrotoxicity and subsequent defect in the process of MTX excretion. The recombinant form of glucarpidase is produced by engineered E. coli and is a confirmed choice to overcoming this problem. Objective: In the present study, in silico analyses were performed to select suitable S Read More
-
-
-
In Vivo Treatment Efficacy of Essential Oil Isolated from Seeds of Momordica charantia in Streptozotocin-Induced Diabetes Mellitus
Background: All parts of Momordica charantia L. have potential hypoglycemic properties in reversing the metabolic disorder of diabetes mellitus. However, there exists a need for preparing an effective and safer formulation of active phytochemicals. We have also reviewed and analyzed certain patents on such preparatory methods for Momordica charantia L. formulations. Objective: This study aimed to isolate essential o Read More
-
Volumes & issues
-
Volume 19 (2025)
-
Volume 18 (2024)
-
Volume 17 (2023)
-
Volume 16 (2022)
-
Volume 15 (2021)
-
Volume 14 (2020)
-
Volume 13 (2019)
-
Volume 12 (2018)
-
Volume 11 (2017)
-
Volume 10 (2016)
-
Volume 9 (2015)
-
Volume 8 (2014)
-
Volume 7 (2013)
-
Volume 6 (2012)
-
Volume 5 (2011)
-
Volume 4 (2010)
-
Volume 3 (2009)
-
Volume 2 (2008)
-
Volume 1 (2007)
Most Read This Month
Article
content/journals/biot
Journal
10
5
false
en
